- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/21 - Retroviridae, e.g. equine infectious anemia virus
Patent holdings for IPC class A61K 39/21
Total number of patents in this class: 1602
10-year publication summary
|
82
|
94
|
97
|
81
|
81
|
73
|
63
|
74
|
52
|
15
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Duke University | 3161 |
97 |
| The Trustees of the University of Pennsylvania | 4387 |
57 |
| The Scripps Research Institute | 1341 |
51 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2947 |
45 |
| International AIDS Vaccine Initiative | 92 |
44 |
| Triad National Security, LLC | 619 |
37 |
| Janssen Vaccines & Prevention B.V. | 297 |
27 |
| Massachusetts Institute of Technology | 10183 |
25 |
| The Regents of the University of California | 20410 |
23 |
| American Gene Technologies International Inc. | 89 |
20 |
| Beth Israel Deaconess Medical Center, Inc. | 862 |
20 |
| Centre National de La Recherche Scientifique | 10812 |
19 |
| Emory University | 1688 |
17 |
| Oregon Health & Science University | 759 |
17 |
| Glaxosmithkline Biologicals S.A. | 1620 |
16 |
| California Institute of Technology | 4015 |
16 |
| Inovio Pharmaceuticals, Inc. | 325 |
16 |
| Baylor Research Institute | 226 |
15 |
| Los Alamos National Security, LLC | 292 |
15 |
| New York University | 1801 |
15 |
| Other owners | 1010 |